Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 421

1.

Bark coverage shifts assembly processes of microbial decomposer communities in dead wood.

Hagge J, Bässler C, Gruppe A, Hoppe B, Kellner H, Krah FS, Müller J, Seibold S, Stengel E, Thorn S.

Proc Biol Sci. 2019 Oct 9;286(1912):20191744. doi: 10.1098/rspb.2019.1744. Epub 2019 Oct 9.

PMID:
31594501
2.

The Meaningless Meaning of Mean Heart Dose in Mediastinal Lymphoma in the Modern Radiotherapy Era.

Hoppe BS, Bates JE, Mendenhall NP, Morris CG, Louis D, Ho MW, Hoppe R, Shaikh M, L Z, Flampouri S.

Pract Radiat Oncol. 2019 Oct 2. pii: S1879-8500(19)30279-6. doi: 10.1016/j.prro.2019.09.015. [Epub ahead of print]

3.

Subclinical myocardial disease in patients with primary hyperoxaluria and preserved left ventricular ejection fraction: a two-dimensional speckle-tracking imaging study.

Lagies R, Udink Ten Cate FEA, Feldkötter M, Beck BB, Sreeram N, Hoppe B, Herberg U.

Pediatr Nephrol. 2019 Aug 22. doi: 10.1007/s00467-019-04330-7. [Epub ahead of print]

PMID:
31440827
4.

Crystal deposition triggers tubule dilation that accelerates cystogenesis in polycystic kidney disease.

Torres JA, Rezaei M, Broderick C, Lin L, Wang X, Hoppe B, Cowley BD Jr, Savica V, Torres VE, Khan S, Holmes RP, Mrug M, Weimbs T.

J Clin Invest. 2019 Jul 30;130:4506-4522. doi: 10.1172/JCI128503.

5.

Intrafractional Displacement of Cardiac Substructures Among Patients With Mediastinal Lymphoma or Lung Cancer.

Guzhva L, Flampouri S, Mendenhall NP, Morris CG, Hoppe BS.

Adv Radiat Oncol. 2019 Mar 29;4(3):500-506. doi: 10.1016/j.adro.2019.03.008. eCollection 2019 Jul-Sep.

6.

Immunotherapy with hypofractionated radiotherapy in metastatic non-small cell lung cancer: An analysis of the National Cancer Database.

Bates JE, Morris CG, Milano MT, Yeung AR, Hoppe BS.

Radiother Oncol. 2019 Sep;138:75-79. doi: 10.1016/j.radonc.2019.06.004. Epub 2019 Jun 25.

PMID:
31252297
7.

Radiation-induced tumor immunity in patients with non-small cell lung cancer.

Lockney NA, Zhang M, Morris CG, Nichols RC, Okunieff P, Swarts S, Zhang Z, Zhang B, Zhang A, Hoppe BS.

Thorac Cancer. 2019 Jul;10(7):1605-1611. doi: 10.1111/1759-7714.13122. Epub 2019 Jun 22.

8.

Management of bone disease in cystinosis: Statement from an international conference.

Hohenfellner K, Rauch F, Ariceta G, Awan A, Bacchetta J, Bergmann C, Bechtold S, Cassidy N, Deschenes G, Elenberg E, Gahl WA, Greil O, Harms E, Herzig N, Hoppe B, Koeppl C, Lewis MA, Levtchenko E, Nesterova G, Santos F, Schlingmann KP, Servais A, Soliman NA, Steidle G, Sweeney C, Treikauskas U, Topaloglu R, Tsygin A, Veys K, V Vigier R, Zustin J, Haffner D.

J Inherit Metab Dis. 2019 Sep;42(5):1019-1029. doi: 10.1002/jimd.12134. Epub 2019 Aug 5.

PMID:
31177550
9.

Comparison of Techniques for Involved-Site Radiation Therapy in Patients With Lower Mediastinal Lymphoma.

Everett AS, Hoppe BS, Louis D, McDonald AM, Morris CG, Mendenhall NP, Li Z, Flampouri S.

Pract Radiat Oncol. 2019 May 22. pii: S1879-8500(19)30134-1. doi: 10.1016/j.prro.2019.05.009. [Epub ahead of print]

10.

Degrees and dollars - Health costs associated with suboptimal ambient temperature exposure.

Liu Y, Saha S, Hoppe BO, Convertino M.

Sci Total Environ. 2019 Aug 15;678:702-711. doi: 10.1016/j.scitotenv.2019.04.398. Epub 2019 Apr 29.

PMID:
31078861
11.

The ocular phenotype in primary hyperoxaluria type 1.

Birtel J, Herrmann P, Garrelfs SF, Dulz S, Atiskova Y, Diederen RM, Gliem M, Brinkert F, Holz FG, Boon CJF, Hoppe B, Charbel Issa P.

Am J Ophthalmol. 2019 May 10. pii: S0002-9394(19)30218-1. doi: 10.1016/j.ajo.2019.04.036. [Epub ahead of print]

PMID:
31078535
12.

Cause of Discrepancy.

Kiesewetter H, Hoppe B.

Dtsch Arztebl Int. 2019 Mar 29;116(13):220. doi: 10.3238/arztebl.2019.0220b. No abstract available.

13.

Rare Variants in BNC2 Are Implicated in Autosomal-Dominant Congenital Lower Urinary-Tract Obstruction.

Kolvenbach CM, Dworschak GC, Frese S, Japp AS, Schuster P, Wenzlitschke N, Yilmaz Ö, Lopes FM, Pryalukhin A, Schierbaum L, van der Zanden LFM, Kause F, Schneider R, Taranta-Janusz K, Szczepańska M, Pawlaczyk K, Newman WG, Beaman GM, Stuart HM, Cervellione RM, Feitz WFJ, van Rooij IALM, Schreuder MF, Steffens M, Weber S, Merz WM, Feldkötter M, Hoppe B, Thiele H, Altmüller J, Berg C, Kristiansen G, Ludwig M, Reutter H, Woolf AS, Hildebrandt F, Grote P, Zaniew M, Odermatt B, Hilger AC.

Am J Hum Genet. 2019 May 2;104(5):994-1006. doi: 10.1016/j.ajhg.2019.03.023.

14.

Thank you to those who Peer Reviewed in 2018 for Advances in Radiation Oncology.

Miller RC, Deville C, Goyal S, Hintenlang KM, Hoppe BS, Jackson IL, Kim S, Small W Jr, Tsai CJ, Videtic G, Yashar C, Knoll MA, Tegbaru D.

Adv Radiat Oncol. 2019 Apr 16;4(2):211-217. doi: 10.1016/j.adro.2019.03.001. eCollection 2019 Apr-Jun. No abstract available.

15.

Patient-Reported Sexual Survivorship Following High-Dose Image-Guided Proton Therapy for Prostate Cancer.

Holtzman AL, Bryant CM, Mendenhall NP, Mendenhall WM, Nichols RC, Henderson RH, Figura N, Morris CG, Williams CR, Li Z, Hoppe BS.

Radiother Oncol. 2019 May;134:204-210. doi: 10.1016/j.radonc.2019.01.029. Epub 2019 Feb 27.

PMID:
31005217
16.

Serum Testosterone 60 Months after Passive-Scatter Proton Therapy for Localized Prostate Cancer.

Nichols RC, Morris CG, Bryant C, Hoppe BS, Henderson RH, Mendenhall WM, Li Z, Costa JA, Williams CR, Mendenhall NP.

Cancer Invest. 2019;37(2):85-89. doi: 10.1080/07357907.2019.1565766. Epub 2019 Mar 5.

PMID:
30836776
17.

Direct grafting-from of PEDOT from a photoreactive Zr-based MOF - a novel route to electrically conductive composite materials.

Mohmeyer A, Schaate A, Hoppe B, Schulze HA, Heinemeyer T, Behrens P.

Chem Commun (Camb). 2019 Mar 14;55(23):3367-3370. doi: 10.1039/c8cc10298h.

PMID:
30816376
18.

Clinical Outcomes of Patients With Recurrent Lung Cancer Reirradiated With Proton Therapy on the Proton Collaborative Group and University of Florida Proton Therapy Institute Prospective Registry Studies.

Badiyan SN, Rutenberg MS, Hoppe BS, Mohindra P, Larson G, Hartsell WF, Tsai H, Zeng J, Rengan R, Glass E, Katz S, Vargas C, Feigenberg SJ, Simone CB 2nd.

Pract Radiat Oncol. 2019 Jul - Aug;9(4):280-288. doi: 10.1016/j.prro.2019.02.008. Epub 2019 Feb 23.

PMID:
30802618
19.

Proton therapy for thymic malignancies: multi-institutional patterns-of-care and early clinical outcomes from the proton collaborative group and the university of Florida prospective registries.

Mercado CE, Hartsell WF, Simone CB 2nd, Tsai HK, Vargas CE, Zhu HJ, Henderson RH, Zeng J, Larson GL, Hoppe BS.

Acta Oncol. 2019 Jul;58(7):1036-1040. doi: 10.1080/0284186X.2019.1575981. Epub 2019 Feb 20.

PMID:
30784340
20.

Molecular fungal community and its decomposition activity in sapwood and heartwood of 13 temperate European tree species.

Leonhardt S, Hoppe B, Stengel E, Noll L, Moll J, Bässler C, Dahl A, Buscot F, Hofrichter M, Kellner H.

PLoS One. 2019 Feb 14;14(2):e0212120. doi: 10.1371/journal.pone.0212120. eCollection 2019.

21.

Home-Field Advantage in Wood Decomposition Is Mainly Mediated by Fungal Community Shifts at "Home" Versus "Away".

Purahong W, Kahl T, Krüger D, Buscot F, Hoppe B.

Microb Ecol. 2019 Oct;78(3):725-736. doi: 10.1007/s00248-019-01334-6. Epub 2019 Feb 13.

PMID:
30761423
22.

Impact of unfavorable factors on outcomes among inoperable stage II-IV Nonsmall cell lung cancer patients treated with proton therapy.

Zhu HJ, Nichols RC, Henderson RH, Morris CG, Flampouri S, Pham DC, Klassen CL, Seeram V, Cury JD, Jones L, McGee L, Hoppe BS.

Acta Oncol. 2019 Mar;58(3):313-319. doi: 10.1080/0284186X.2018.1546060. Epub 2019 Jan 18.

PMID:
30656994
23.

Pediatric in-hospital emergencies: real life experiences, previous training and the need for training among physicians and nurses.

Lehmann R, Seitz A, Meyburg J, Hoppe B, Hoffmann GF, Tönshoff B, Huwendiek S.

BMC Res Notes. 2019 Jan 14;12(1):19. doi: 10.1186/s13104-019-4051-4.

24.

PTV margin analysis for prostate patients treated with initial pelvic nodal IMRT and prostate proton boost.

Su Z, Li Z, Henderson R, Hoppe B, Nichols RC, Bryant C, Mendenhall W, Mendenhall N.

Phys Med Biol. 2019 Feb 8;64(4):04NT04. doi: 10.1088/1361-6560/aafd75.

PMID:
30630135
25.

Association of Combined Modality Therapy vs Chemotherapy Alone With Overall Survival in Early-Stage Pediatric Hodgkin Lymphoma.

Jhawar SR, Rivera-Núñez Z, Drachtman R, Cole PD, Hoppe BS, Parikh RR.

JAMA Oncol. 2019 May 1;5(5):689-695. doi: 10.1001/jamaoncol.2018.5911.

PMID:
30605220
26.

Endurance training during maintenance hemodialysis in pediatric and adolescent patients-theory and best practice suggestions.

Schaar B, Thys S, Hoppe B.

Pediatr Nephrol. 2019 Jan 2. doi: 10.1007/s00467-018-4182-1. [Epub ahead of print]

PMID:
30603808
27.

Novel therapeutic approaches in primary hyperoxaluria.

Weigert A, Martin-Higueras C, Hoppe B.

Expert Opin Emerg Drugs. 2018 Dec;23(4):349-357. doi: 10.1080/14728214.2018.1552940. Epub 2018 Dec 12.

PMID:
30540923
28.

Rapid liquid chromatography tandem mass-spectrometry screening method for urinary metabolites of primary hyperoxaluria.

Woodward G, Pryke R, Hoppe B, Rumsby G.

Ann Clin Biochem. 2019 Mar;56(2):232-239. doi: 10.1177/0004563218811365. Epub 2018 Nov 14.

PMID:
30373392
29.

Determinants of Deadwood-Inhabiting Fungal Communities in Temperate Forests: Molecular Evidence From a Large Scale Deadwood Decomposition Experiment.

Purahong W, Wubet T, Lentendu G, Hoppe B, Jariyavidyanont K, Arnstadt T, Baber K, Otto P, Kellner H, Hofrichter M, Bauhus J, Weisser WW, Krüger D, Schulze ED, Kahl T, Buscot F.

Front Microbiol. 2018 Sep 20;9:2120. doi: 10.3389/fmicb.2018.02120. eCollection 2018.

30.

Letter to the editor in response to Hopper et al, "Salvage image guided radiation therapy to the prostate after cryotherapy failure".

Holtzman A, Hoppe BS.

Adv Radiat Oncol. 2018 Feb 9;3(3):469. doi: 10.1016/j.adro.2018.02.002. eCollection 2018 Jul-Sep. No abstract available.

31.

Targeting kidney inflammation as a new therapy for primary hyperoxaluria?

Martin-Higueras C, Ludwig-Portugall I, Hoppe B, Kurts C.

Nephrol Dial Transplant. 2019 Jun 1;34(6):908-914. doi: 10.1093/ndt/gfy239.

PMID:
30169827
32.

ITV-Based Robust Optimization for VMAT Planning of Stereotactic Body Radiation Therapy of Lung Cancer.

Liang X, Zheng D, Mamalui-Hunter M, Flampouri S, Hoppe BS, Mendenhall N, Li Z.

Pract Radiat Oncol. 2019 Jan;9(1):38-48. doi: 10.1016/j.prro.2018.08.005. Epub 2018 Aug 20.

PMID:
30138747
33.

Bacteria inhabiting deadwood of 13 tree species are heterogeneously distributed between sapwood and heartwood.

Moll J, Kellner H, Leonhardt S, Stengel E, Dahl A, Bässler C, Buscot F, Hofrichter M, Hoppe B.

Environ Microbiol. 2018 Oct;20(10):3744-3756. doi: 10.1111/1462-2920.14376. Epub 2018 Sep 17.

PMID:
30109768
34.

Proton therapy for adults with mediastinal lymphomas: the International Lymphoma Radiation Oncology Group guidelines.

Dabaja BS, Hoppe BS, Plastaras JP, Newhauser W, Rosolova K, Flampouri S, Mohan R, Mikhaeel NG, Kirova Y, Specht L, Yahalom J.

Blood. 2018 Oct 18;132(16):1635-1646. doi: 10.1182/blood-2018-03-837633. Epub 2018 Aug 14. Erratum in: Blood. 2019 Mar 21;133(12):1384-1385.

35.

Stereotactic Ablative Body Radiotherapy for Primary Non-Small-Cell Lung Cancer: Achieving Local Control with a Lower Biologically Effective Dose.

Zhu S, Lightsey JL, Hoppe BS, Okunieff P, Gopalan PK, Kaye FJ, Morris CG, Yeung AR.

Cancer Invest. 2018;36(5):289-295. doi: 10.1080/07357907.2018.1479415. Epub 2018 Jul 24.

PMID:
30040495
36.

Metabolic profile and impact of diet in patients with primary hyperoxaluria.

Siener R, Hoppe B, Löhr P, Müller SC, Latz S.

Int Urol Nephrol. 2018 Sep;50(9):1583-1589. doi: 10.1007/s11255-018-1939-1. Epub 2018 Jul 23.

PMID:
30039216
37.

Extracorporeal membrane oxygenation support in a newborn with lower urinary tract obstruction and pulmonary hypoplasia: a case report.

Gatzweiler E, Hoppe B, Dewald O, Berg C, Müller A, Reutter H, Kipfmueller F.

J Med Case Rep. 2018 Jul 17;12(1):210. doi: 10.1186/s13256-018-1749-1.

38.

Kidney regeneration in fish.

Bates T, Naumann U, Hoppe B, Englert C.

Int J Dev Biol. 2018;62(6-7-8):419-429. doi: 10.1387/ijdb.170335ce. Review.

39.

Proton therapy for pediatric malignancies: Fact, figures and costs. A joint consensus statement from the pediatric subcommittee of PTCOG, PROS and EPTN.

Weber DC, Habrand JL, Hoppe BS, Hill Kayser C, Laack NN, Langendijk JA, MacDonald SM, McGovern SL, Pater L, Perentesis JP, Thariat J, Timmerman B, Yock TI, Mahajan A.

Radiother Oncol. 2018 Jul;128(1):44-55. doi: 10.1016/j.radonc.2018.05.020. Epub 2018 Jun 21. Review.

PMID:
29937209
40.

Effects of different management regimes on microbial biodiversity in vineyard soils.

Hendgen M, Hoppe B, Döring J, Friedel M, Kauer R, Frisch M, Dahl A, Kellner H.

Sci Rep. 2018 Jun 20;8(1):9393. doi: 10.1038/s41598-018-27743-0.

41.

Rationale and early outcomes for the management of thymoma with proton therapy.

Zhu HJ, Hoppe BS, Flampouri S, Louis D, Pirris J, Nichols RC, Henderson RH, Mercado CE.

Transl Lung Cancer Res. 2018 Apr;7(2):106-113. doi: 10.21037/tlcr.2018.04.06.

42.

Improving Male Reproductive Health After Childhood, Adolescent, and Young Adult Cancer: Progress and Future Directions for Survivorship Research.

Kenney LB, Antal Z, Ginsberg JP, Hoppe BS, Bober SL, Yu RN, Constine LS, van Santen HM, Skinner R, Green DM.

J Clin Oncol. 2018 Jul 20;36(21):2160-2168. doi: 10.1200/JCO.2017.76.3839. Epub 2018 Jun 6. Review.

PMID:
29874140
43.

Translation inhibition corrects aberrant localization of mutant alanine-glyoxylate aminotransferase: possible therapeutic approach for hyperoxaluria.

Belostotsky R, Lyakhovetsky R, Sherman MY, Shkedy F, Tzvi-Behr S, Bar R, Hoppe B, Reusch B, Beck BB, Frishberg Y.

J Mol Med (Berl). 2018 Jul;96(7):621-630. doi: 10.1007/s00109-018-1651-8. Epub 2018 May 18.

PMID:
29777253
44.

Risk Factors for Early Dialysis Dependency in Autosomal Recessive Polycystic Kidney Disease.

Burgmaier K, Kunzmann K, Ariceta G, Bergmann C, Buescher AK, Burgmaier M, Dursun I, Duzova A, Eid L, Erger F, Feldkoetter M, Galiano M, Geßner M, Goebel H, Gokce I, Haffner D, Hooman N, Hoppe B, Jankauskiene A, Klaus G, König J, Litwin M, Massella L, Mekahli D, Melek E, Mir S, Pape L, Prikhodina L, Ranchin B, Schild R, Seeman T, Sever L, Shroff R, Soliman NA, Stabouli S, Stanczyk M, Tabel Y, Taranta-Janusz K, Testa S, Thumfart J, Topaloglu R, Weber LT, Wicher D, Wühl E, Wygoda S, Yilmaz A, Zachwieja K, Zagozdzon I, Zerres K; ESCAPE Study Group; GPN Study Group, Dötsch J, Schaefer F, Liebau MC; ARegPKD consortium.

J Pediatr. 2018 Aug;199:22-28.e6. doi: 10.1016/j.jpeds.2018.03.052. Epub 2018 May 9.

PMID:
29753540
45.

Rectal Culture and Sensitivity Analysis for Reducing Sepsis Risk After Fiducial Marker Placement.

Mendenhall WM, Sarto G, Bryant CM, Morris CG, Williams CR, Costa JA, Bandyk M, Hoppe BS, Henderson RH, Nichols RC, Mendenhall NP.

Am J Clin Oncol. 2018 Dec;41(12):1243-1245. doi: 10.1097/COC.0000000000000454.

PMID:
29727310
46.

Nephrolithiasis and Nephrocalcinosis in Childhood-Risk Factor-Related Current and Future Treatment Options.

Weigert A, Hoppe B.

Front Pediatr. 2018 Apr 12;6:98. doi: 10.3389/fped.2018.00098. eCollection 2018. Review.

47.

[Biomarkers and imaging for diagnosis and stratification of rheumatoid arthritis and spondylarthritis in the BMBF consortium ArthroMark].

Häupl T, Skapenko A, Hoppe B, Skriner K, Burkhardt H, Poddubnyy D, Ohrndorf S, Sewerin P, Mansmann U, Stuhlmüller B, Schulze-Koops H, Burmester GR.

Z Rheumatol. 2018 May;77(Suppl 1):16-23. doi: 10.1007/s00393-018-0458-x. Review. German.

PMID:
29691690
48.

A classic twin study of lower urinary tract obstruction: Report of 3 cases and literature review.

Frese S, Weigert A, Hoppe B, Feldkötter M, Ludwig M, Weber S, Kiliś-Pstrusińska K, Zaniew M, Reutter H, Hilger AC.

Low Urin Tract Symptoms. 2019 Apr;11(2):O85-O88. doi: 10.1111/luts.12222. Epub 2018 Apr 17.

PMID:
29664229
49.

Report from the SWOG Radiation Oncology Committee: Research Objectives Workshop 2017.

Okunieff P, Casey-Sawicki K, Lockney NA, Hoppe BS, Enderling H, Pinnix C, Welsh J, Krishnan S, Yothers G, Brown M, Knox S, Bristow R, Spellman P, Mitin T, Nabavizadeh N, Jaboin J, Manning HC, Feng F, Galbraith S, Solanki AA, Harkenrider MM, Tuli R, Decker RH, Finkelstein SE, Hsu CC, Ha CS, Jagsi R, Shumway D, Daly M, Wang TJC, Fitzgerald TJ, Laurie F, Marshall DT, Raben D, Constine L, Thomas CR Jr, Kachnic LA.

Clin Cancer Res. 2018 Aug 1;24(15):3500-3509. doi: 10.1158/1078-0432.CCR-17-3202. Epub 2018 Apr 16.

50.

Threshold Evaluation of Emergency Risk Communication for Health Risks Related to Hazardous Ambient Temperature.

Liu Y, Hoppe BO, Convertino M.

Risk Anal. 2018 Oct;38(10):2208-2221. doi: 10.1111/risa.12998. Epub 2018 Apr 10.

PMID:
29637591

Supplemental Content

Support Center